Navigation Links
Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R)

less than 10% of men with hypogonadism currently receive testosterone replacement therapy.

About Testim

Testim is a proprietary, clear, topical gel containing 1% testosterone, the same type of hormone that is produced by the human body. When applied once-daily to the upper arms and shoulders, clinical studies have shown that Testim will restore and maintain testosterone levels. Once Testim is absorbed through the skin, it enters the bloodstream and helps return testosterone to normal levels. The efficacy of Testim has been demonstrated in 16 clinical studies involving approximately 1,800 patients, including the largest placebo- controlled study ever conducted to evaluate the benefits and risks of testosterone replacement therapy. For information regarding the safety and use of Testim, please see the prescribing information at http://www.testim.com.

About Auxilium

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical development. AA4500, an injectable collagenase enzyme, is in phase III of development for the treatment of Dupuytren's contracture and is in phase II of development for the treatment of Peyronie's disease and Frozen Shoulder syndrome (Adhesive Capsulitis). Auxilium's transmucosal film product candidate for the treatment of overactive bladder (AA4010) is in phase I of development. The Company is currently seeking a partner to further develop this product candidate. Auxilium has two pain products using its transmucosal film delivery system in pre-clinical development. Auxilium has rights to six additional pain products and products for hormone re
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
(Date:11/30/2008)...- Abnormalities in auditory and language processin...m disorder by using magnetoencephalography (MEG), ... meeting of the Radiological Society of North Amer...he tiny magnetic fields associated with electrical...e chair of research in the Department of Radiology...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...ewswire/ -- Proteolix, Inc., a,leader in the disc...arget,protein degradation pathways in cancer and ...om two ongoing Phase 2 clinical trials of carfilzo...upcoming 50th Annual Meeting of the,American Soci... in a new class,of specific proteasome inhibitors...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 1New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 1Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 3Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 1Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 1bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 3
...RD, Calif.--(BUSINESS WIRE)--Jul 5, 2007 - Scienti...ed so many suspects and,found so many treatments w...s an enigma. Now researchers at the Stanford,Unive...ing,principle that could explain how a range of ca... found that in rats the differing mechanisms of de...
...III clinical trial provides hope that HIV patients... 2007 /PRNewswire/ -- A new,investigational drug u...roven to be effective in fighting drug-resistant H...in its July 7th,special HIV/AIDS issue. , The mult... 18,nations and more than 30 centers in the United...
Other Medicine Technology:Stanford Researchers Find Brain Pathway of Depression in Rats 2Stanford Researchers Find Brain Pathway of Depression in Rats 3Stanford Researchers Find Brain Pathway of Depression in Rats 4New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 2New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 3
(Date:12/2/2008)...t 10 New Cellular Therapies Will Launch Over Next ...sources , , WALTHAM, Mass., Dec. 2 /PRNewsw...ding research and advisory firms for pharmaceutica...herapies drug market will experience robust growth...ng $1.5 billion in 2017. According to the new spec...
(Date:12/2/2008)... China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Chin...or "the Company") (Nasdaq: CSKI ), a leading,fu...er-the-counter drugs in,the People,s Republic of ...anley) Hao was appointed Chief Financial Officer a... Board of Directors. He replaces Yu-kun Zhang, wh...
(Date:12/2/2008)..., Dec. 2 New research estimates th...hospitals with the highest risk-adjusted,mortalit...ABG) surgery,performed as well as hospitals with ...he mortality rate for women was higher than men re...tial increased as performance declined.,The study...
(Date:12/2/2008)...D, Calif., Dec. 2 Genopt...ry services provider, today announced the Company,...althcare Conference scheduled to take place at the... 10-11, 2008. , , Sam Riccitelli, COO and...art in a panel discussion at the conference on Wed...
Breaking Medicine News(10 mins):Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 3Health News:New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals 2Health News:New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals 3Health News:Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference 2
...ught in a number of issues which is corrupting the...led with dwindling// numbers of health workers, ha...ealthcare education. Australian Medical Associatio...There is a very real potential that parents and st...
...f mental health crisis because of the lack of prop...sed by the Mental Health Commission.// The report... people would be taken to acute inpatient services...esearch was conducted by Hilary Lapsley and Heathe...
.../AIDS epidemic could affect the Indian economy a... on the Macroeconomic// and Sectoral Impacts of HI...ouncil of Applied Economic Research (NCAER) and su...pment Programme (UNDP) and National AIDS Control O...
...on of the BSF to terminate the services of a BSF p...isability on account of contracting the dreaded HI...rmination was being upheld on the ground that the ...the ailment and not because of his contracting HIV...
Other Medicine News:Health News:More Effective Mental Health Services Required 2Health News:HIV/AIDS Epidemic to Cause Adverse Effects to Indian Economy 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: